Retirements Reported in DEA's DIVERSION as "DOGE CASUALTIES". "The DOJ admits the system is illegal, yet the DEA keeps using it to punish medical research," Boise stated. "This is a shadow court ...
CLEVELAND, Ohio (WOIO) - The Drug Enforcement Administration (DEA) is trying to keep prescription drugs from getting into the wrong hands. We looked into how they’re making sure pharmacies and doctors ...
DEA Back to Training School, DEA Bureaucrat Blocks Science While Ignoring their Own TRAINING Manual. DEA Assistant Administrators and attorney needs a summer assignment, and MMJ BioPharma Cultivation ...
The DEA Diversion Control Problem: A Hidden Threat to U.S. Pharmaceutical Manufacturing ? Take the case of MMJ BioPharma Cultivation - despite submissions of FDA Investigational New Drug (IND) ...
Unjustified Delays: MMJ International Holdings claims that these officials have been instrumental in the multi-year delays of their application to cultivate pharmaceutical-grade marijuana, necessary ...
The Compliance Team is hosting a webinar with Elena Jacques, diversion program specialist with the Drug Enforcement Administration, Diversion Control Division, on Thursday, Aug. 14, from 2:00 pm – ...
The DEA "Slow Walk" MMJ Scandal: DEA Stalls Pharmaceutical Development, Defying President Trump's Agenda The Department of Justice (DOJ) recently distanced itself from certain administrative practices ...
A couple of recent large-scale enforcement actions suggest that the U.S. Department of Justice (DOJ) may be placing increased emphasis on targeting black market prescription drug diversion. This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results